跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REDESCA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
REDESCA
Authorized
STANDARD
REDESCA
Shenzhen Techdow Pharmaceutical Co., Ltd.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
846b72d8f38eb439
Company
Shenzhen Techdow Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
846b72d8f38eb439
Drug Approval Canada Name
REDESCA
Product Name
REDESCA
Status
Marketed
Status Date
2021-04-09
Original Market Date
2021-04-09
Din
02509113
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous , Subcutaneous
Schedule
Prescription
Ahfs
20:12.04.16
Atc Original
B01AB05 ENOXAPARIN
Atc Name
b 01 ab 05
Aig Number
0131860001
Company Name
Shenzhen Techdow Pharmaceutical Co., Ltd.
Company Address
No. 1 Rongtian South, Kengzi Sub-District, Pingshan New District, Shenzhen City, --, China, 518122
Company Detail Path
/organization/shenzhen-techdow-pharmaceutical-co-ltd
Company Information
Pharmaceutical Company Name
Shenzhen Techdow Pharmaceutical Co., Ltd.
Country Name
China
Province Name
广东省
City Name
广东省深圳市
Address
No.19, Gaoxinzhongyi Road, Nanshan District
Website
http://cn.techdow.com
Active Ingredients
ENOXAPARIN SODIUM
100 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
846b72d8f38eb439
Type
Standard
Back to Health Canada Approvals